Illumina price target raised to $330 from $275 at Citi. Citi analyst Daniel Arias raised his price target on Illumina to $330 and maintained a Buy rating, telling investors in a research note that the Nova cycle is “on track,” the full portfolio is driving “good” demand and the company appears to be opening doors on sevearl large TAM opportunities that can enhance its growth profile.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.